Alyeska Investment Group, L.P. Oric Pharmaceuticals, Inc. Transaction History

Alyeska Investment Group, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$15.9 - $25.22 $2.78 Million - $4.41 Million	-175,000 Reduced 61.42%	109,945 $2.3 Million
Q2 2021 Aug 16, 2021	SELL	$17.37 - $25.34 $8,685 - $12,670	-500 Reduced 0.18%	284,945 $5.04 Million
Q1 2021 May 17, 2021	BUY	$23.67 - $36.85 $865,067 - $1.35 Million	36,547 Added 14.68%	285,445 $6.99 Million
Q4 2020 Feb 16, 2021	BUY	$20.32 - $39.8 $1.77 Million - $3.48 Million	87,313 Added 54.04%	248,898 $8.43 Million
Q2 2020 Aug 14, 2020	BUY	$25.68 - $38.12 $4.15 Million - $6.16 Million	161,585 New	161,585 $5.45 Million

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.